|
DRUG
DISCOVERY |
DRUG
DEVELOPMENT |
POST
LAUNCH |
M
E
D
I
C
A
L |
-
Identification of new technologies
-
Identification of in-licensing
opportunities
-
Intellectual property strategy
|
|
|
F
I
N
A
N
C
E |
- In-licensing financial structure
- Financial modeling of business development
opportunities
- Pipeline financial modeling for multi-indication
or multi-drug investments
|
-
Financial modeling of
process routes
-
Financial modeling of CRO
contracts
-
Financial analysis for
API/contract manufacturers
|
|
M
A
R
K
E
T
I
N
G |
|
|
- Market research for new indications
|